Pacira BioSciences (PCRX) Operating Leases (2019 - 2026)
Pacira BioSciences (PCRX) posted quarterly Operating Leases of $33.7 million for Q1 2026, down 22.83% year-over-year from $43.7 million in Q1 2025, and down 6.83% quarter-over-quarter from $36.2 million in Q4 2025.
Pacira BioSciences (PCRX) Operating Leases (2019 - 2026) Analysis & Trends
Pacira BioSciences' Operating Leases history runs 8 years deep, the most recent figure standing at $33.7 million for Q1 2026.
- In Q1 2026, Operating Leases fell 22.83% year-over-year to $33.7 million; the TTM figure through Mar 2026 stood at $33.7 million (down 22.83% YoY), while the FY2025 annual figure was $36.2 million, down 18.97% from the prior year.
- Operating Leases for Q1 2026 stood at $33.7 million, down from $36.2 million in the prior quarter.
- The five-year high for Operating Leases was $77.7 million in Q1 2022, with the low at $33.7 million in Q1 2026.
- The 5-year median for Operating Leases is $54.8 million (2023), against an average of $54.4 million.
- The sharpest annual moves came in 2022 and 2025: Operating Leases gained 11.57% in 2022, then slumped 31.94% in 2025.
- Pacira BioSciences' Operating Leases stood at $64.8 million in 2022, then declined by 15.43% to $54.8 million in 2023, then retreated by 18.54% to $44.6 million in 2024, then decreased by 18.97% to $36.2 million in 2025, then fell by 6.83% to $33.7 million in 2026.
- Business Quant data shows PCRX's Operating Leases at $33.7 million in Q1 2026, $36.2 million in Q4 2025, and $38.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Pacira BioSciences | 944.13 Mn | 693.10 Mn | 148.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.99 Mn |
| Mar 31, 2026 | 33.71 Mn |
| Dec 31, 2025 | 36.18 Mn |
| Sep 30, 2025 | 38.84 Mn |
| Jun 30, 2025 | 41.29 Mn |
| Mar 31, 2025 | 43.68 Mn |
| Dec 31, 2024 | 44.65 Mn |
| Sep 30, 2024 | 57.07 Mn |
| Jun 30, 2024 | 50.15 Mn |
| Mar 31, 2024 | 52.45 Mn |
| Dec 31, 2023 | 54.81 Mn |
| Sep 30, 2023 | 65.71 Mn |
| Jun 30, 2023 | 60.05 Mn |
| Mar 31, 2023 | 62.44 Mn |
| Dec 31, 2022 | 64.80 Mn |
| Sep 30, 2022 | 65.40 Mn |
| Jun 30, 2022 | 75.71 Mn |
| Mar 31, 2022 | 77.73 Mn |
| Dec 31, 2021 | 71.73 Mn |
| Sep 30, 2021 | 72.66 Mn |